0.64
+0.0183(+2.94%)
Currency In USD
| Previous Close | 0.62 |
| Open | 0.62 |
| Day High | 0.66 |
| Day Low | 0.62 |
| 52-Week High | 4 |
| 52-Week Low | 0.5 |
| Volume | 204,170 |
| Average Volume | 547,530 |
| Market Cap | 11.38M |
| PE | -0.22 |
| EPS | -2.91 |
| Moving Average 50 Days | 0.65 |
| Moving Average 200 Days | 0.96 |
| Change | 0.02 |
If you invested $1000 in Lifeward Ltd. (LFWD) 10 years ago, it would be worth $0.33 as of December 17, 2025 at a share price of $0.64. Whereas If you bought $1000 worth of Lifeward Ltd. (LFWD) shares 5 years ago, it would be worth $61.76 as of December 17, 2025 at a share price of $0.64.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
GlobeNewswire Inc.
Dec 03, 2025 1:00 PM GMT
Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees This latest approval will help enhance timely access to cutting
UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton
GlobeNewswire Inc.
Nov 17, 2025 1:00 PM GMT
Approval marks continued progress in expanding reimbursement pathways and accelerating access to advanced personal exoskeleton technology for individuals with spinal cord injury.MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 17, 2025 (GLOBE NEW
Lifeward to Report Third Quarter Financial Results on November 14, 2025
GlobeNewswire Inc.
Nov 10, 2025 12:00 PM GMT
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations